🇺🇸 FDA
Patent

US 6060505

Method of treating cancer using C-26 modified bryostatin

expired A61KA61K31/365

Quick answer

US patent 6060505 (Method of treating cancer using C-26 modified bryostatin) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/365